PI3Kδ Inhibitor Parsaclisib Combined With Chidamide for the Treatment of Relapsed/Refractory Peripheral T-cell Lymphoma
Clinical trial NCT05083208 · TERMINATED
Trial details
- NCT number
- NCT05083208
- Sponsor
- Henan Cancer Hospital
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-20
- Primary completion
- 2024-06-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.